Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1987 Mar;79(3):847-52.
doi: 10.1172/JCI112893.

Hereditary xanthinuria. Evidence for enhanced hypoxanthine salvage

Case Reports

Hereditary xanthinuria. Evidence for enhanced hypoxanthine salvage

F A Mateos et al. J Clin Invest. 1987 Mar.

Abstract

We tested the hypothesis that there is an enhanced rate of hypoxanthine salvage in two siblings with hereditary xanthinuria. We radiolabeled the adenine nucleotide pool with [8-14C]adenine and examined purine nucleotide degradation after intravenous fructose. The cumulative excretion of radioactivity during a 5-d period was 9.7% and 9.1% of infused radioactivity in the enzyme-deficient patients and 6.0 +/- 0.7% (mean +/- SE) in four normal subjects. Fructose infusion increased urinary radioactivity to 7.96 and 9.16 X 10(6) cpm/g creatinine in both patients and to 4.73 +/- 0.69 X 10(6) cpm/g creatinine in controls. The infusion of fructose increased total urinary purine excretion to a mean of 487% from low-normal baseline values in the patients and to 398 +/- 86% in control subjects. In the enzyme-deficient patients, the infusion of fructose elicited an increase of plasma guanosine from undetectable values to 0.7 and 0.9 microM. With adjustments made for intestinal purine loss, these data support the hypothesis that there is enhanced hypoxanthine salvage in hereditary xanthinuria. Degradation of guanine nucleotides to xanthine bypasses the hypoxanthine salvage pathway and may explain the predominance of this urinary purine compound in xanthinuria.

PubMed Disclaimer

References

    1. Ann Intern Med. 1966 Feb;64(2):229-58 - PubMed
    1. J Clin Invest. 1965 Jul;44:1248-60 - PubMed
    1. N Engl J Med. 1968 Feb 8;278(6):287-93 - PubMed
    1. J Clin Invest. 1968 Jun;47(6):1325-32 - PubMed
    1. Ann Intern Med. 1969 Jan;70(1):155-206 - PubMed

Publication types